World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
75517
World Ranking
9057
National Ranking
4673

Research.com Recognitions

  • 2013 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1996 - Fellow of the American Statistical Association (ASA)

Overview

Barry R. Davis is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily lies within the field of Medicine, with a notable focus on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Genetics, and Economics and Econometrics.

The scientist's main topics of work include blood pressure and hypertension studies, hormonal regulation and hypertension, heart rate variability and autonomic control, cardiovascular syncope and autonomic disorders, health systems with economic evaluations and quality of life, cardiac health and mental health, and lipoproteins with cardiovascular health.

Barry R. Davis has contributed to multiple recent publications. Selected papers include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021, The Lancet)
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022, The Lancet)
  • A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial (2021, European Journal of Heart Failure)
  • Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis (2021, The Lancet)

Barry R. Davis frequently publishes research in several venues including the Journal of Hypertension, Hypertension, The Lancet, European Heart Journal, and UNC Libraries.

Co-authorship collaboration plays a significant role in their work, with frequent co-authors including Carl J. Pepine, John Chalmers, Kazem Rahimi, Milad Nazarzadeh, and Dexter Canoy.

The scientist has been recognized by professional societies with awards such as Fellow of the American Association for the Advancement of Science (AAAS) since 2013 and Fellow of the American Statistical Association (ASA) since 1996.

Best Publications

  • The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

    F. M. Sacks;M. A. Pfeffer;L. A. Moye;J. L. Rouleau

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL

    Marc A. Pfeffer;Eugene Braunwald;Lemuel A. Moyé;Lofty Basta

  • Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

    Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Barry R Davis

  • Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care

    Curt D. Furberg;Jackson T. Wright;Barry R. Davis;Jeffrey A. Cutler

  • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials

    J Fulcher;R O'Connell;M Voysey

  • Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

    William C. Cushman;Charles E. Ford;Jeffrey A. Cutler;Karen L. Margolis

  • Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial

    Ronald B. Goldberg;Margot J. Mellies;Frank M. Sacks;Lemuel A. Moyé

  • Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients With Isolated Systolic Hypertension

    J. David Curb;Sara L. Pressel;Jeffrey A. Cutler;Peter J. Savage

  • Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease

    Marcello Tonelli;Frank Sacks;Malcolm Arnold;Lemuel A Moye

  • Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension

    Kostis Jb;Davis Br;Cutler J;Grimm Rh

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

    Barry R Davis;Jeffrey A. Cutler;David J. Gordon;Curt D. Furberg

  • Isolated systolic hypertension : prognostic information provided by pulse pressure.

    Michael J. Domanski;Barry R. Davis;Marc A. Pfeffer;Mark Kastantin

  • Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin The Cholesterol and Recurrent Events (CARE) Study

    Jonathan F. Plehn;Barry R. Davis;Frank M. Sacks;Jean L. Rouleau

  • Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial

    Sandra J. Lewis;Lemuel A. Moye;Frank M. Sacks;David E. Johnstone

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Change in Depression as a Precursor of Cardiovascular Events

    Sylvia Wassertheil-Smoller;William B. Applegate;Kenneth Berge;Chee Jen Chang

Frequent Co-Authors

William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Paul K. Whelton
Paul K. Whelton Tulane University
Jeffrey A. Cutler
Jeffrey A. Cutler National Institutes of Health
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham
Henry R. Black
Henry R. Black New York University School of Medicine
John B. Kostis
John B. Kostis Rutgers, The State University of New Jersey
Jeffrey L. Probstfield
Jeffrey L. Probstfield University of Washington
Jackson T. Wright
Jackson T. Wright Case Western Reserve University
Lemuel A. Moyé
Lemuel A. Moyé The University of Texas Health Science Center at Houston
Mahboob Rahman
Mahboob Rahman Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of related healthcare careers. Online degrees offer accessible pathways to many of these in-demand roles. For example, you may consider starting with a medical coding certification online, which prepares you for administrative positions in healthcare. This is a practical entry point for those looking to join the medical field quickly.

If hands-on patient care appeals to you, there are opportunities to advance as a nurse. Numerous cheapest nurse practitioner programs are available online, making it cost-effective to specialize further. Likewise, those aiming to fast-track their nursing career can research cheapest online accelerated bsn programs to quickly obtain a bachelor's in nursing.

For experienced nurses seeking leadership or research roles, pursuing an online phd nursing is a flexible way to advance expertise and open new career pathways. Each of these online programs supports the growing need for skilled healthcare professionals, helping you shape a career that fits your goals and lifestyle.

Best Scientists Citing Barry R. Davis

Trending Scientists